Literature DB >> 6310300

Naloxone-induced hypodipsia: a CNS mapping study.

D A Czech, E A Stein, M J Blake.   

Abstract

Opiate antagonists have been shown to reliably attenuate drinking behavior. Recent research points to a central site of action for this antidipsogenic effect. To pursue this issue of site specificity, naloxone, a specific opiate antagonist, was delivered into a number of discrete subcortical areas in 23 hour water-deprived rats. Water intake was measured at 5, 15, 30 and 60 minutes post drug injection. Compared to saline control injections, naloxone reliably depressed water intake, in a dose-related manner, in lateral hypothalamus, preoptic area and zona incerta. Previous research has repeatedly implicated these areas in drinking behavior. Placements which were not generally effective included lateral ventricle, nucleus accumbens, substantia nigra and cortex/corpus callosum. Latency to drink was never affected by any dose of naloxone injected into any site, suggesting an opioid influence on mechanisms involved in termination and/or maintenance rather than on initiation of drinking.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310300     DOI: 10.1016/0024-3205(83)90786-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Effect of fractionated extracts and isolated pure compounds of Spondias mombin (L. Anacardiaceae) leaves on novelty-induced rearing and grooming behaviours in mice.

Authors:  Abiodun O Ayoka; Rotimi A Owolabi; Samuel K Bamitale; Rufus O Akomolafe; Joseph A Aladesanmi; Eghe O Ukponmwan
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-08-12

2.  Suppression of deprivation-induced water intake in the rat by opioid antagonists: central sites of action.

Authors:  M Ukai; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 3.  A role for benzamil-sensitive proteins of the central nervous system in the pathogenesis of salt-dependent hypertension.

Authors:  Joanna M Abrams; John W Osborn
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-05       Impact factor: 2.557

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.